Why it matters
Green vein leaf is generally harvested mid-cycle and dried under conditions that limit fermentation and UV exposure compared with reds. The resulting alkaloid distribution tends to preserve more mitragynine relative to the oxidation products, which user reports characterise as a “middle” profile — alert and functional at low doses, with some relaxation creeping in higher up.
In practice
For new consumers, green vein is the most common starting point because the profile is less polarised. Standard dosing advice still applies: start at the low end of the published range, observe response over at least 30–45 minutes, and titrate from there rather than re-dosing immediately. Batch consistency from a COA-publishing vendor matters more for a “balanced” profile than for an extreme one because small alkaloid shifts move the experience more.
Common confusion
Vein colour is not a precise pharmacological category. Two “greens” from different vendors, or even different batches from the same vendor, can have meaningfully different mitragynine percentages and trace-alkaloid ratios. Treat the label as a starting hypothesis and the COA as the actual evidence.
This glossary entry is editorial content reviewed against primary sources. It is not medical advice. See our Editorial Policy.